Related Experiment Video
Updated: May 2, 2026
05:06
Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
2.6K
Peer support to decrease diabetes-related distress in patients with type 2 diabetes mellitus: design of a randomised
Lianne de Vries1, Amber Awa van der Heijden, Esther van 't Riet
1Department of General Practice and Elderly Care Medicine, VU University Medical Center, Amsterdam, The Netherlands. li.devries@vumc.nl.
BMC Endocrine Disorders
|March 6, 2014
Summary
Peer support programs can help manage type 2 diabetes mellitus distress. This study designs a theoretically-grounded group intervention to evaluate its effectiveness in reducing diabetes-related distress.
Area of Science:
- Clinical Psychology
- Behavioral Medicine
- Endocrinology
Background:
- Type 2 diabetes mellitus (T2DM) patients struggle with self-management, leading to significant diabetes-related distress.
- Peer support offers a promising avenue for distress reduction, leveraging shared experiences and mutual motivation.
- Existing evidence for peer support interventions in T2DM is inconsistent due to weak theoretical underpinnings.
Purpose of the Study:
- To design and evaluate a theoretically-grounded, group-based peer support program for T2DM patients.
- To assess the intervention's effectiveness in reducing diabetes-related distress.
- To explore impacts on self-management, well-being, and quality of life.
Main Methods:
- A parallel-group randomized controlled trial comparing a six-session peer support intervention with an educational meeting.
- Recruitment of 152 T2DM patients (3+ years duration, aged 50-70) via general practitioners.
- Intervention development aligned with the Medical Research Council framework, measuring outcomes at baseline, 6, and 12 months post-intervention.
Main Results:
- Primary outcome: reduction in diabetes-related distress.
- Secondary outcomes: improvements in self-management behavior, well-being, and health-related quality of life.
- Process measure: perceived social support.
Conclusions:
- This study will provide insights into the effectiveness of a theoretically-informed peer support intervention for T2DM.
- Findings aim to strengthen the evidence base for peer support in managing patient-reported outcomes.
- The research addresses the need for robust interventions to mitigate diabetes-related distress.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
01:29Chronic Pancreatitis II: Collaborative Care
563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
563
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17